Home / RyanMolinari


UK Pharmaceutical Company Caught Bribing Competitors

The pharmaceutical firm GlaxoSmithKline has been caught paying competing companies to stop the release of a generic version of its antidepressant drug Seroxat. The United Kingdom’s Competition and Markets Authority discovered that GSK paid over £50 million ($72.5 million) to five producers of the generic version of Seroxat, paroxetine, between ...

Read More »